| CEO Name | Steffen Lang |
| Nationality | Germany |
| Net Worth Estimation | $5,000,000 |
Steffen Lang's estimated net worth of around $5 million USD is derived from his executive salary, bonuses, equity compensation, and possible long-term incentive plans accumulated during his leadership roles at CSL Vifor and previously at Novartis. Additional wealth factors include performance-based stock awards and professional tenure within the global pharmaceutical industry.
Steffen Lang's estimated net worth of 5,000,000 USD is 5% of the maximum (90,000,000 USD) and 50% of the minimum (10,000,000 USD) CEO net worth for the healthcare sector. His wealth is below the industry's average CEO net worth range.
Business Category: Healthcare
Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 90000000 USD
Steffen Lang Performance in Vifor Pharma AG (now CSL Vifor)
Steffen Lang, CEO of Vifor Pharma AG (now CSL Vifor), demonstrated decisive leadership by driving strategic growth and operational excellence in specialty pharma. He enhanced decision-making frameworks focused on innovation, market expansion, and sustainability, significantly improving company performance and shareholder value. Lang's impact is evident in strengthened global partnerships and accelerated product pipelines, solidifying CSL Vifor's market position in kidney and iron deficiency therapies.
Latest News
CSL Vifor Pharma: Company Updates and Leadership under CEO Abbas Hussain
CSL Vifor Pharma, formerly Vifor Pharma AG, has been led by CEO Abbas Hussain since August 2021. The company underwent significant corporate changes, including an $11.7 billion acquisition by CSL Ltd. in 2022, integrating its nephrology-focused pharmaceutical portfolio and advancing products like FILSPARI for kidney disease; recently, CSL Vifor committed to a PS23 million payment to the NHS to resolve competition concerns related to intravenous iron treatments.
Source: http://newsroom.csl.com/csl-vifor